Fresenius Medical Care | FME - Beneficio Bruto En Ventas

Precio De Mercado
37.74
Cambio Diario
-0.53 -1.38%
Mensual
-8.82%
Anual
-16.13%
Q1 Expectativa
36.66




Beneficio Bruto En Ventas Cambio Fecha
Akzo Nobel EUR 1.04B 10M 2025-06
Alcon AG USD 1.52B 58M 2025-12
AstraZeneca USD 12.39B 5M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Beiersdorf EUR 1.54B 1.16B 2025-06
DaVita Healthcare Partners USD 1.02B 63.9M 2025-12
Demant DKK 8.82B 277M 2025-12
E.ON EUR 4.63B 663M 2025-09
Essilor EUR 8.3B 547M 2025-12
Fresenius EUR 1.51B 214M 2025-12
Fresenius Medical Care EUR 1.39B 147M 2025-12
Genmab DKK 977M 13M 2025-12
Getinge SEK 5.05B 1.5B 2024-12
Givaudan CHF 1.55B 140M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
GN Store Nord DKK 2.5B 344M 2025-12
GRIFOLS EUR 743.8M 49.13M 2025-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lonza CHF 1.29B 248M 2025-06
Merck EUR 2.96B 252M 2025-12
Novartis USD 10.25B 570M 2025-12
Philips EUR 2.29B 377M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
RWE EUR 723M 820M 2025-09
Sanofi EUR 8.45B 1.31B 2025-12
SAP EUR 7.12B 451M 2025-12
Smith & Nephew USD 2.09B 117M 2025-12